By John Harbison|2017-02-20T06:54:58-08:00December 13, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Cognition Therapeutics Initiates US Clinical Testing Of CT1812, A Novel Small Molecule For The Potential Treatment Of Alzheimer’s Disease
